Humana (NYSE: HUM) insider transactions
In the twelve months to 10 November 2026, executives and directors of Humana reported 0 open-market sales and 1 open-market purchase of 810 shares ($150,020), by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 September 2026 | Nundy Shantanu | Chief Medical Officer | Grant or award | +2,549 | — | 2,549 | Form 4 |
| 1 August 2026 | Crawford Frederick John | Director | Grant or award | +544 | — | 544 | Form 4 |
| 1 August 2026 | Smith Paul John | Director | Grant or award | +544 | — | 544 | Form 4 |
| 1 May 2026 | Mellet Celeste | Chief Financial Officer | Grant or award | −15,387 | — | 39,637 | Form 4 |
| 1 May 2026 | Ventura Joseph C | Chief Legal Officer | Grant or award | +10,318 | — | 27,405 | Form 4 |
| 1 May 2026 | O'Hara Michelle A. | Chief Human Resources Officer | Grant or award | +10,485 | — | 20,026 | Form 4 |
| 1 May 2026 | Shetty Sanjay K | President, CenterWell | Grant or award | +9,945 | — | 22,088 | Form 4 |
| 1 May 2026 | Rechtin James A. | President & CEO | Grant or award | +35,633 | — | 63,938 | Form 4 |
| 1 May 2026 | Dintenfass David | President, Enterprise Growth | Grant or award | +11,273 | — | 25,407 | Form 4 |
| 1 May 2026 | Mehta Japan | Chief Information Officer | Grant or award | +9,448 | — | 17,176 | Form 4 |
| 1 May 2026 | Martin Aaron | President, Medicare Advantage | Grant or award | +8,206 | — | 25,237 | Form 4 |
| 1 May 2026 | Field Robert Stuart | Director | Grant or award | +852 | — | 852 | Form 4 |
| 1 April 2026 | Shetty Sanjay K | President, CenterWell | Option exercise | +887 | — | 12,544 | Form 4 |
| 1 April 2026 | Shetty Sanjay K | President, CenterWell | Shares withheld for tax | −401 | $175.44 | 12,143 | Form 4 |
| 24 February 2026 | Ventura Joseph C | Chief Legal Officer | Option exercise | +1,035 | — | 17,565 | Form 4 |
| 24 February 2026 | Ventura Joseph C | Chief Legal Officer | Shares withheld for tax | −478 | $177.08 | 17,087 | Form 4 |
| 24 February 2026 | Renaudin George II | President, Insurance | Option exercise | +1,035 | — | 16,494 | Form 4 |
| 24 February 2026 | Renaudin George II | President, Insurance | Shares withheld for tax | −419 | $177.08 | 16,075 | Form 4 |
| 24 February 2026 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Option exercise | +165 | — | 7,568 | Form 4 |
| 24 February 2026 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Shares withheld for tax | −84 | $177.08 | 7,484 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Humana page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.